When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALPMF - FDA OKs Astellas' gilteritinib for certain type of leukemia; shares up 2%
Astellas Pharma Inc
The FDA approves Astellas Pharma's (OTCPK:ALPMF) Xospata (gilteritinib) for the treatment of adult patients with relapsed/refractory FLT3 mutation-positive acute myeloid leukemia (AML).
More news on: Astellas Pharma, Inc., Healthcare stocks news, Stocks on the move,